United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s) - 1. indications  progestin- only oral contraceptives are indicated for the prevention of pregnancy. 2. efficacy if used perfectly, the first-year failure rate for progestin- only oral contraceptives is 0.5%. however, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills. the following table lists the pregnancy rates for users of all major methods of contraception. emergency contraceptive pills treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.9 lactational amenorrhea method lam is a highly effective, temporary method of contraception.10 source: trussell, j, contraceptive efficacy. in: hatcher ra, trussell j, stewart f, cates w, stewart gk, kowal d, guest f, contraceptive technology: seventeenth revised edition. new york ny: irvington publishers, 1998. - among typical couples who initiate use of a method (not necessarily for the first time), the percentage who exp

United States - English - NLM (National Library of Medicine)

naari pte. limited - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s) - 1. indications. progestin-only oral contraceptives are indicated for the prevention of pregnancy. 2. efficacy. if used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.5%. however, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills. the following table lists the pregnancy rates for users of all major methods of contraception. emergency contraceptive pills: treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%. 9 lactational amenorrhea method: lam is a highly effective, temporary method of contraception. 10 source: trussell, j, contraceptive efficacy. in: hatcher ra, trussell j, stewart f, cates w, stewart gk, kowal d, guest f, contraceptive technology: seventeenth revised edition. new york ny: irvington publishers, 1998. - among typical couples who initiate use of a method (not necessarily for the first time), the percen

United States - English - NLM (National Library of Medicine)

a-s medication solutions - ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u), norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s) - pirmella 7/7/7 and pirmella 1/35 tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant® system depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. source: trussel j, contraceptive efficacy. in hatcher ra, trussel j, stewart f, cates w, stewart gk, kowal d, guest f, contraceptive technology: seventeenth revised edition. new york ny: irvington publishers, 1998. pirmella 7/7/7 and pirmella 1/35 have not been studied for and are not indicated for use in emergency contraception. pirmella 7/7/7 and pirmella 1/35 is  contraindicated in females who are known to have or develop the following conditions: - thrombop

United States - English - NLM (National Library of Medicine)

princeton biotechnology corporation - arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), calendula officinalis flowering top (unii: 18e7415pxq) (calendula officinalis flowering top - unii:18e7415pxq), echinacea angustifolia (unii: vb06av5us8) (echinacea angustifolia - unii:vb06av5us8), st. john's wort (unii: ufh8805fka) (st. john's wort - unii:ufh8805fka), silver (unii: 3m4g523w1g) (silver - unii:3m4g523w1g), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70), allylthiourea (unii: 706idj14b7) (allylthiourea - unii:70 - arnica montana 30 {kp_c} in 60 ml - ahealon is indicated for the acute and chronic treatment of pain and or inflammation, as well as a general healing aid, an infection deterrent, an agent to help reduce scar tissue and a source of moisturization (dry/cracked/burned skin), that include: all burn injuries, radiation dermatitis, surgical incisions, rashes, pruritic conditions, arthritis/joint pain, lower back pain, wounds, pressure sores, tumors, neuropathic discomfort and any generally painful and or inflamed area. pain remediation can secondarily benefit sleep quality and duration; pain reduction can also relieve chronic stress induced cortisol production and thus contribute to less patient stress and anxiety and the reversal of chronic non-healing wounds. expedited use on pain/trauma patients may quickly control pain such as to reduce the possibility of shock. although there are no known contraindications, patients who are allergic to any ahealon ingredient should consult a physician prior to taking the medication. (refer to section on hyperse

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate pentahydrate, quantity: 20 mg - tablet, film coated - excipient ingredients: povidone; lactose; magnesium stearate; purified talc; pregelatinised maize starch; titanium dioxide; sunset yellow fcf aluminium lake; polyvinyl alcohol; macrogol 3350; erythrosine aluminium lake - treatment of chronic severe pain of cancer.

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - tablet, modified release - excipient ingredients: purified talc; lactose; hyetellose; magnesium stearate; cetostearyl alcohol; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - ms contin is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. ms contin is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. ms contin is not indicated as an as-needed (prn) analgesia.

Canada - English - Health Canada

pharmaceutical partners of canada inc - vancomycin (vancomycin hydrochloride) - powder for solution - 500mg - vancomycin (vancomycin hydrochloride) 500mg - glycopeptides

Canada - English - Health Canada

janssen inc - norethindrone - tablet - 0.35mg - norethindrone 0.35mg - contraceptives